Citicoline protects against cognitive impairment in a rat model of chronic cerebral hypoperfusion

Journal of Clinical Neurology (Korea)

Volumn 5, Issue 1, 2009, Pages 33-38

  Lee, Hyun Joon ^a   Kang, Ji Seung ^a   Kim, Yeong In ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Chronic cerebral hypoperfusion; Citicoline; Cognitive impairment; Rat; White matter damage

Indexed keywords

EID: 78651468459     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2009.5.1.33     Document Type: Article

References (22)

1. Sachdev PS, Brodaty H, Looi JC. Vascular dementia: diagnosis, management and possible prevention. Med J Aust 1999;170:81-85.
2. Farkas E, Donka G, de Vos RA, Mihály A, Bari F, Luiten PG. Experimental cerebral hypoperfusion induces white matter injury and mic-roglial activation in the rat brain. Acta Neuropathol 2004;108:57-64.
3. Stenset V, Hofoss D, Berstad AE, Negaard A, Gjerstad L, Fladby T. White matter lesion subtypes and cognitive deficits in patients with memory impairment. Dement Geriatr Cogn Disord 2008;26:424-431.
4. Fisher CM. Binswanger's encephalopathy: a review. J Neurol 1989; 236:65-79.
5. Wakita H, Tomimoto H, Akiguchi I, Kimura J. Glial activation and white matter changes in the rat brain induced by chronic cerebral hy-poperfusion: an immunohistochemical study. Acta Neuropathol 1994; 87:484-492.
6. Kim JE, Lee BR, Chun JE, Lee SJ, Lee BH, Yu IK, et al. Cognitive Dysfunction in 16 patients with carotid stenosis: detailed neuropsycho-logical Findings. J Clin Neurol 2007;3:9-17.
7. Kumaran D, Udayabanu M, Kumar M, Aneja R, Katyal A. Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats. Neuroscience 2008;155:626-639.
8. Otori T, Katsumata T, Katayama Y, Terashi A. Measurement of regional cerebral blood flow and glucose utilization in rat brain under chronic hypoperfusion conditions following bilateral carotid artery occlusion. Analyzed by autoradiographical methods. Nippon Ika Dai-gaku Zasshi 1997;64:428-439.
9. Tomimoto H, Akiguchi I, Wakita H, Kimura J. White matter lesions after occlusion of the bilateral carotid arteries in the rat--temporal profile of cerebral blood flow (CBF), oligodendroglia and myelin. No To Shinkei 1997;49:639-644.
10. Tsuchiya M, Sako K, Yura S, Yonemasu Y. Cerebral blood flow and histopathological changes following permanent bilateral carotid artery ligation in Wistar rats. Exp Brain Res 1992;89:87-92.
11. Adibhatla RM, Hatcher JF. Citicoline mechanisms and clinical efficacy in cerebral ischemia. J Neurosci Res 2002;70:133-139.
12. Adibhatla RM, Hatcher JF, Dempsey RJ. Citicoline: neuroprotective mechanisms in cerebral ischemia. J Neurochem 2002;80:12-23.
13. Hurtado O, Moro MA, Cárdenas A, Sánchez V, Fernández-Tomé P, Leza JC, et al. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport. Neurobiol Dis 2005;18:336-345.
14. Davidson CM, Pappas BA, Stevens WD, Fortin T, Bennett SA. Chronic cerebral hypoperfusion: loss of pupillary reflex, visual impairment and retinal neurodegeneration. Brain Res 2000;859:96-103.
15. Paxinos G, Watson C. The rat brain in stereotaxic coodinates. 4th ed. San Diego: Academic press, 1998.
16. Wakita H, Tomimoto H, Akiguchi I, Kimura J. Dose-dependent, protective effect of FK506 against white matter changes in the rat brain after chronic cerebral ischemia. Brain Res 1998;792:105-113.
17. Tomimoto H, Ihara M, Wakita H, Ohtani R, Lin JX, Akiguchi I, et al. Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat. Acta Neuro-pathol 2003;106:527-534.
18. Parnetti L, Mignini F, Tomassoni D, Traini E, Amenta F. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation? J Neurol Sci 2007; 257:264-269.
19. Onal MZ, Li F, Tatlisumak T, Locke KW, Sandage BW Jr, Fisher M. Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats. Stroke 1997;28:1060-1065.
20. Paul RH, Cohen RA, Moser DJ, Ott BR, Sethi M, Sweet L, et al. Clinical correlates of cognitive decline in vascular dementia. Cogn Behav Neurol 2003;16:40-46.
21. Agut J, Lopez G-Coviella I, Ortiz JA, Wurtman RJ. Oral cytidine 5'-diphosphate choline administration to rats increases brain phospholipid levels. Ann N Y Acad Sci 1993;695:318-320.
22. Secades JJ, Lorenzo JL. Citicoline: pharmacological and clinical review, 2006 update. Methods Find Exp Clin Pharmacol 2006;28 Suppl B:1-56.